Hong Seng's healthcare arm HS Bio acquires two industrial properties


Hong Seng executive director and HS Bio director Christopher Chan

KUALA LUMPUR: Hong Seng Consolidated Bhd has proposed to acquire a 100% stake in Premiumway Development Sdn Bhd (PDSB) for RM1.09mil.

In a filing with Bursa Malaysia, Hong Seng said its unit Neogenix Laboratoire Sdn Bhd (Neogenix Lab) had entered into a shares sale agreement (SSA) with the Ong Kah Hoe and Ong Kim Chong @ Ong Hwee Choo to undertake the proposed acquisition of one million ordinary shares, or 100% equity interest in PDSB.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Chin Hin taps Ajiya for two-year RM250mil loan
MI Technovation posts three-fold surge in net profit
CIMB Securities eyes larger market share
InNature diversifies into the F&B industry
Yinson’s RM16bil debt too big to ignore
Leap in operating income for UOB’s retail banking
Paramount emerges as major shareholder in EWI
New capacity in the pipeline
March industrial production index up 2.4%, but below forecast
Data centre – boon or bane?

Others Also Read